340 related articles for article (PubMed ID: 3893106)
1. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
[TBL] [Abstract][Full Text] [Related]
2. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
[TBL] [Abstract][Full Text] [Related]
4. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.
Gruber SA; Pescovitz MD; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Fryd DS
Transplantation; 1987 Dec; 44(6):775-8. PubMed ID: 3321586
[TBL] [Abstract][Full Text] [Related]
5. Allograft renal vascular thrombosis--lack of increase with cyclosporine immunosuppression.
Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
Transplantation; 1989 Mar; 47(3):475-8. PubMed ID: 2646779
[TBL] [Abstract][Full Text] [Related]
6. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
Kupin WL; Venkatachalam KK; Oh HK; Dienst S; Levin NW
Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029
[TBL] [Abstract][Full Text] [Related]
7. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
Boudreaux JP; McHugh L; Canafax DM; Ascher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine.
Hall BM; Tiller DJ; Duggin GG; Horvath JS; Farnsworth A; May J; Johnson JR; Sheil AG
Kidney Int; 1985 Aug; 28(2):178-86. PubMed ID: 3914572
[TBL] [Abstract][Full Text] [Related]
10. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital.
Milford EL; Kirkman RL; Tilney NL; Strom TB; Carpenter CB
Am J Kidney Dis; 1985 Jun; 5(6):313-7. PubMed ID: 3925762
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
[TBL] [Abstract][Full Text] [Related]
13. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
Sumrani N; Delaney V; Ding ZK; Butt K; Hong J
Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine in renal transplantation: a single institutional experience.
Ferguson RM; Sommer BG
Am J Kidney Dis; 1985 Jun; 5(6):296-306. PubMed ID: 3925761
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
Canadian Multicentre Transplant Study Group
N Engl J Med; 1986 May; 314(19):1219-25. PubMed ID: 2871486
[TBL] [Abstract][Full Text] [Related]
16. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry M; Ferguson RM
Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Hesse UJ; Fryd DS; Chatterjee SN; Simmons RL; Sutherland DE; Najarian JS
Arch Surg; 1986 Sep; 121(9):1056-60. PubMed ID: 3527111
[TBL] [Abstract][Full Text] [Related]
19. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?
Marcén R; Pascual J; Teruel JL; Villafruela JJ; Rivera ME; Mampaso F; Burgos FJ; Ortuño J
Transplantation; 2001 Jul; 72(1):57-62. PubMed ID: 11468535
[TBL] [Abstract][Full Text] [Related]
20. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
Hanto DW; Jendrisak MD; So SK; McCullough CS; Rush TM; Michalski SM; Phelan D; Mohanakumar T
Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]